Raymond James & Associates’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $7.88M | Buy |
124,202
+24,709
| +25% | +$1.78M | ﹤0.01% | 1362 |
|
|
2024
Q2 | $6.72M | Sell |
99,493
-18,067
| -15% | -$1.26M | ﹤0.01% | 1383 |
|
|
2024
Q1 | $9.31M | Buy |
117,560
+19,618
| +20% | +$1.6M | 0.01% | 1204 |
|
|
2023
Q4 | $7.62M | Buy |
97,942
+21,894
| +29% | +$1.62M | 0.01% | 1274 |
|
|
2023
Q3 | $5.35M | Buy |
76,048
+424
| +0.6% | +$31.7K | ﹤0.01% | 1418 |
|
|
2023
Q2 | $6.02M | Buy |
75,624
+4,678
| +7% | +$338K | 0.01% | 1355 |
|
|
2023
Q1 | $5.13M | Buy |
70,946
+2,979
| +4% | +$232K | ﹤0.01% | 1443 |
|
|
2022
Q4 | $5.6M | Sell |
67,967
-639
| -0.9% | -$52.7K | 0.01% | 1330 |
|
|
2022
Q3 | $5.36M | Sell |
68,606
-1,539
| -2% | -$123K | 0.01% | 1331 |
|
|
2022
Q2 | $4.74M | Sell |
70,145
-13,445
| -16% | -$938K | ﹤0.01% | 1433 |
|
|
2022
Q1 | $5.48M | Sell |
83,590
-15,420
| -16% | -$896K | ﹤0.01% | 1449 |
|
|
2021
Q4 | $6.01M | Sell |
99,010
-30
| -0% | -$1.79K | ﹤0.01% | 1435 |
|
|
2021
Q3 | $6.32M | Sell |
99,040
-238
| -0.2% | -$15K | 0.01% | 1348 |
|
|
2021
Q2 | $6.23M | Buy |
99,278
+863
| +0.9% | +$54.1K | 0.01% | 1348 |
|
|
2021
Q1 | $5.62M | Buy |
98,415
+7,223
| +8% | +$391K | 0.01% | 1355 |
|
|
2020
Q4 | $4.58M | Buy |
91,192
+20,832
| +30% | +$830K | 0.01% | 1388 |
|
|
2020
Q3 | $2.07M | Sell |
70,360
-5,098
| -7% | -$148K | ﹤0.01% | 1744 |
|
|
2020
Q2 | $1.9M | Buy |
75,458
+5,110
| +7% | +$128K | ﹤0.01% | 1765 |
|
|
2020
Q1 | $1.29M | Sell |
70,348
-4,529
| -6% | -$130K | ﹤0.01% | 1830 |
|
|
2019
Q4 | $2.49M | Sell |
74,877
-3,673
| -5% | -$115K | ﹤0.01% | 1692 |
|
|
2019
Q3 | $2.44M | Sell |
78,550
-5,981
| -7% | -$182K | ﹤0.01% | 1651 |
|
|
2019
Q2 | $2.95M | Buy |
84,531
+11,385
| +16% | +$368K | ﹤0.01% | 1556 |
|
|
2019
Q1 | $2.14M | Buy |
73,146
+462
| +0.6% | +$13.1K | ﹤0.01% | 1721 |
|
|
2018
Q4 | $1.87M | Sell |
72,684
-14,163
| -16% | -$490K | ﹤0.01% | 1702 |
|
|
2018
Q3 | $3.06M | Buy |
86,847
+8,890
| +11% | +$354K | ﹤0.01% | 1540 |
|
|
2018
Q2 | $3.19M | Sell |
77,957
-2,986
| -4% | -$120K | 0.01% | 1459 |
|
|
2018
Q1 | $3.17M | Sell |
80,943
-20,169
| -20% | -$740K | 0.01% | 1418 |
|
|
2017
Q4 | $3.3M | Buy |
101,112
+14,687
| +17% | +$509K | 0.01% | 1370 |
|
|
2017
Q3 | $4.13M | Buy |
86,425
+9,126
| +12% | +$445K | 0.01% | 1180 |
|
|
2017
Q2 | $3.82M | Buy |
77,299
+40,859
| +112% | +$1.81M | 0.01% | 1165 |
|
|
2017
Q1 | $1.59M | Sell |
36,440
-16,369
| -31% | -$664K | ﹤0.01% | 1679 |
|
|
2016
Q4 | $1.75M | Sell |
52,809
-12,181
| -19% | -$473K | ﹤0.01% | 1569 |
|
|
2016
Q3 | $3.22M | Buy |
64,990
+18,965
| +41% | +$988K | 0.01% | 1172 |
|
|
2016
Q2 | $2.55M | Buy |
46,025
+1,539
| +3% | +$90K | 0.01% | 1199 |
|
|
2016
Q1 | $2.45M | Buy |
44,486
+2,924
| +7% | +$167K | 0.01% | 1169 |
|
|
2015
Q4 | $2.6M | Buy |
41,562
+2,075
| +5% | +$135K | 0.01% | 1126 |
|
|
2015
Q3 | $2.62M | Sell |
39,487
-9,334
| -19% | -$718K | 0.01% | 1079 |
|
|
2015
Q2 | $3.82M | Buy |
48,821
+13,281
| +37% | +$956K | 0.01% | 950 |
|
|
2015
Q1 | $2.54M | Buy |
35,540
+18,101
| +104% | +$1.16M | 0.01% | 1115 |
|
|
2014
Q4 | $1.07M | Buy |
+17,439
| New | +$1.01M | 0.01% | 1537 |
|
Other funds holding ACHC
Raymond James & Associates's ACHC Position: Q3 2024 in Review
Raymond James & Associates increased its Acadia Healthcare (ACHC) stake by 25% in Q3 2024, buying an estimated $1.78M and bringing the position to 124,202 shares worth $7.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1362.
Raymond James & Associates first reported a position in ACHC in Q4 2014 and has held it in 40 quarters since. The position peaked at $9.31M in Q1 2024. 312 funds tracked by Wall St. Rank hold ACHC as of Q3 2024.
- Raymond James & Associates held 124,202 shares of Acadia Healthcare worth $7.88M as of Q3 2024.
- Raymond James & Associates bought 24,709 Acadia Healthcare shares in Q3 2024, an estimated $1.78M.
- Acadia Healthcare made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1362 holding.
- Raymond James & Associates first reported a position in Acadia Healthcare in Q4 2014 and has held it in 40 quarters since.
- Raymond James & Associates's Acadia Healthcare position peaked at $9.31M in Q1 2024.
- 312 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.